MARKET

MENS

MENS

Jyong Biotech Ltd.
NASDAQ
3.950
-0.270
-6.40%
After Hours: 4.200 +0.25 +6.33% 19:55 12/31 EST
OPEN
4.330
PREV CLOSE
4.220
HIGH
5.35
LOW
3.900
VOLUME
1.87M
TURNOVER
--
52 WEEK HIGH
67.00
52 WEEK LOW
2.601
MARKET CAP
300.31M
P/E (TTM)
-99.4962
1D
5D
1M
3M
1Y
5Y
1D
Why FuelCell Energy Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga · 12/31/2025 17:40
Axsome Therapeutics, Plug Power And Other Big Stocks Moving Higher On Wednesday
Benzinga · 12/31/2025 15:12
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 12/30/2025 17:05
Weekly Report: what happened at MENS last week (1222-1226)?
Weekly Report · 12/29/2025 09:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 12/23/2025 17:05
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga · 12/23/2025 13:02
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 12/22/2025 17:05
US Stocks Higher; Nasdaq Surges Over 100 Points
Benzinga · 12/22/2025 15:07
More
About MENS
Jyong Biotech Ltd is a Taiwan-based science-driven biotechnology company. The Company is mainly engaged in developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the United States (U.S.), the European Union (EU), and Asia. The Company has been developing a series of botanical drug candidates, including primary botanical drug candidate of MCS-2, another clinical-stage botanical drug candidate of PCP, and other preclinical-stage botanical drug candidates. MCS-2 is a new botanical drug candidate developed for treatment of benign prostate hyperplasia/lower urinary tract symptoms (BPH/LUTS). PCP is a new botanical drug candidate developed for the prevention of prostate cancer.

Webull offers Jyong Biotech Ltd. stock information, including NASDAQ: MENS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MENS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MENS stock methods without spending real money on the virtual paper trading platform.